Baroreflex sensitivity impairment in Long-COVID patients: a diagnostic tool for classifying the autonomic dysfunction spectrum - Top-Institutions - MDSpire

Baroreflex sensitivity impairment in Long-COVID patients: a diagnostic tool for classifying the autonomic dysfunction spectrum

  • By

  • Alejandro Sáinz-Jiménez

  • Ignacio Romero Fragoso

  • Guadalupe Estrella Salazar Calderon

  • Santiago Martinez-Falcon

  • Hannah Molinari Luna

  • Jesus Portocarrero Nieto

  • Andrea Barajas-Aguilar

  • Antonio Barajas-Martínez

  • Isael Guillermo García Macedo

  • Felipe Gonzalez-Alvarez

  • Maria Silvia Lopez-Yañez

  • Brayans Becerra-Luna

  • Raul Martinez-Memije

  • Erwin Chiquete

  • Carlos Cantu

  • Karla Maria Tamez-Torres

  • Jose Sifuentes-Osornio

  • Claudia Lerma

  • Ruben Fossion

  • Tania Reyes-Cruz

  • Bruno Estañol

  • Jose de Jesus Aceves-Buendia

  • July 14, 2026

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Medical Sciences and Nutrition Salvador Zubirán
    National Institute of Medical Sciences and Nutrition Salvador Zubirán

    Mexico City, Mexico

    Key Differentiators

    • Cardiology

  • #2

    University Medical Center Hamburg-Eppendorf
    University Medical Center Hamburg-Eppendorf

    Hamburg, Germany

    Key Differentiators

    • Cardiology

  • #3

    G. Da Saliceto Hospital
    G. Da Saliceto Hospital

    Piacenza, Italy

    Key Differentiators

    • Cardiology

Original Source(s)

Baroreflex sensitivity impairment in Long-COVID patients: a diagnostic tool for classifying the autonomic dysfunction spectrum

  • by Alejandro Sáinz-Jiménez, Ignacio Romero Fragoso, Guadalupe Estrella Salazar Calderon, Santiago Martinez-Falcon, Hannah Molinari Luna, Jesus Portocarrero Nieto, Andrea Barajas-Aguilar, Antonio Barajas-Martínez, Isael Guillermo García Macedo, Felipe Gonzalez-Alvarez, Maria Silvia Lopez-Yañez, Brayans Becerra-Luna, Raul Martinez-Memije, Erwin Chiquete, Carlos Cantu, Karla Maria Tamez-Torres, Jose Sifuentes-Osornio, Claudia Lerma, Ruben Fossion, Tania Reyes-Cruz, Bruno Estañol, Jose de Jesus Aceves-Buendia

  • July 14, 2026

Related Content

GLP-1 RAs Associated With Small ION Risk Increase

In an observational US target trial emulation, glucagon-like peptide-1 receptor agonist initiation was associated with about 3 to 4 more ischemic optic neuropathy cases per 10,000 patients over 18 months than two comparator drug classes.

NF-κB signaling in acute myocardial infarction: pathophysiology, inflammation, and therapeutic implications

Correction: Excessive erythrocytosis and the hypertensive phenotype at high altitude: emerging evidence and unresolved questions